This list is an analysis based on recent market events. It's not an investment recommendation.
About
Artrya Limited is a medical technology firm that harnesses artificial intelligence (AI) to pinpoint individuals at risk of developing coronary artery disease. The company's key offering is Salix, a cloud-based software application. Salix leverages Artrya's proprietary AI to automate the identification of coronary artery disease through the analysis of coronary computed tomography angiography (CCTA) scans. Founded in 2018, the company is headquartered in West Perth, Australia.
The current price of AYA.AU is A$4.18 AUD — it has increased by +0% in the past 24 hours. Watch Artrya stock price performance more closely on the chart.
What is Artrya stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Australia Exchange exchange Artrya stocks are traded under the ticker AYA.AU.
Is Artrya stock price growing?▼
AYA.AU stock has fallen by -12% compared to the previous week, the month change is a -4.57% fall, over the last year Artrya has showed a +91.74% increase.
What is Artrya market cap?▼
Today Artrya has the market capitalization of 681.19M
When is the next Artrya earnings date?▼
Artrya is going to release the next earnings report on March 02, 2027.
What were Artrya earnings last quarter?▼
AYA.AU earnings for the last quarter are -0.09 AUD per share, whereas the estimation was -0.05 AUD resulting in a -61.12% surprise. The estimated earnings for the next quarter are N/A AUD per share.
What is Artrya revenue for the last year?▼
Artrya revenue for the last year amounts to 28,000 AUD.
What is Artrya net income for the last year?▼
AYA.AU net income for the last year is -25.18M AUD.
How many employees does Artrya have?▼
As of September 06, 2026, the company has 43 employees.